Sarepta Therapeutics, Inc.
SRPTNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $1.90B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $14.68$24.68
- Volume (live)
- -
- Avg. volume (3M)
- 2.90M
Sarepta Therapeutics (SRPT) Stock Price & Financial Analysis
Sarepta Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $17.66 - $18.14 |
|---|---|
| 52-Week High | $24.68 |
| 52-Week Low | $14.68 |
| Open | $17.77 |
| Volume (last close) | 1.36M |
| Average Volume (3M) | 2.90M |
| Revenue (TTM) | 1.97B |
|---|---|
| Net Income (TTM) | -136.72M |
| Free Cash Flow (TTM) | 73.30M |
| EPS (TTM) | −$1.26 |
| Profit Margin | -6.93% |
| Operating Margin | -5.28% |
| Return on Equity (ROE) | -8.95% |
| Debt to Equity | 0.55 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.90B |
|---|---|
| Shares Outstanding | 105.43M |
| Price to Sales (P/S) | 0.96 |
| Price to Book (P/B) | 1.24 |
| EV/EBITDA | 15.49 |
| 50-Day MA | $19.24 |
|---|---|
| 200-Day MA | $18.88 |
| 1-Year Change | −16.95% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Sarepta Therapeutics at a Glance
As of the Oct 26, 2026 close, Sarepta Therapeutics (SRPT) has a market capitalization of $1.90B. The stock trades at 1.0× sales. Over the trailing twelve months it lost $136.72M on revenue of $1.97B and generated $73.30M of free cash flow. Revenue fell 20.4% year over year.
As of its latest reported balance sheet, it holds $571.15M in cash and securities against $847.62M of debt, a net debt position of $276.48M.
Sarepta Therapeutics does not currently pay a dividend.
The share price is down 16.9% over the past year. At $17.98 (the Oct 26, 2026 close) it sits within its 52-week range of $14.68 to $24.68, below its 200-day moving average of $18.88.
Based on 17 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $21.53, 19.7% above the Oct 26, 2026 close.
Frequently Asked Questions About Sarepta Therapeutics
What is the current stock price for SRPT?
As of the Oct 26, 2026 close, SRPT stock trades at $17.98. The 52-week range is $14.68–$24.68, with a day range of $17.66–$18.14.
What is the P/E ratio for SRPT?
The P/E ratio (Price-to-Earnings) for SRPT is shown in the Key Statistics section. This valuation metric helps compare Sarepta Therapeutics, Inc. to industry peers.
Does SRPT pay dividends?
Sarepta Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SRPT?
Based on ratings from 17 professional analysts over the last 90 days, the consensus for SRPT is Hold. The average 12-month price target is $21.53, a 19.7% upside from the Oct 26, 2026 close of $17.98.
What is the market cap of SRPT?
As of the Oct 26, 2026 close, Sarepta Therapeutics's market capitalization is $1.90B, classifying it as a small-cap company. Sarepta Therapeutics operates in the Healthcare sector within the Biotechnology industry.